FLOW FORWARD MEDICAL
Flow Forward Medical develops vascular access sites designed to improve post-surgery success rates. The Arteriovenous Fistula Eligibility (AFE) System is a small, temporary, external blood pump designed to stimulate flow-mediated dilation to make more patients eligible for arteriovenous fistula (AVF) and increase success rates after surgery. The establishment of a reliable AVF reduces morbidity and mortality in hemodialysis patients, as well as the overall cost of care. The company was founded in 2014 by Frank Nicholas Franano and is headquartered in Olathe, Kansas.
FLOW FORWARD MEDICAL
Social Links:
Industry:
Health Care Medical Medical Device
Founded:
2014-01-01
Address:
Kansas City, Kansas, United States
Country:
United States
Website Url:
http://www.artiomedical.com
Total Employee:
1+
Status:
Active
Contact:
(913) 440-4439
Email Addresses:
[email protected]
Total Funding:
8.13 M USD
Technology used in webpage:
SPF
Similar Organizations
G Medical Innovations
G Medical Innovations is a next-generation mobile health (mHealth) and e-health company.
Current Employees Featured
Founder
Investors List
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Diabetes and Digestive and Kidney Diseases investment in Grant - Flow Forward Medical
Mid-America Angels
Mid-America Angels investment in Series A - Flow Forward Medical
Kansas Bioscience Authority
Kansas Bioscience Authority investment in Series A - Flow Forward Medical
Kansas Bioscience Authority
Kansas Bioscience Authority investment in Series A - Flow Forward Medical
River Valley Investors
River Valley Investors investment in Series A - Flow Forward Medical
Official Site Inspections
http://www.artiomedical.com
- Host name: 253.180.70.34.bc.googleusercontent.com
- IP address: 34.70.180.253
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Flow Forward Medical"
Artio Medical, Inc. | LinkedIn
ARTIO MEDICAL is developing innovative new medical devices to treat important unmet medical needs for large, global peripheral vascular, neurovascular, and structural heart markets. These products ...See details»
Artio Medical - Crunchbase Company Profile & Funding
Artio Medical develops endovascular medical devices for the embolization of vessels, aneurysms, and other vascular structures.See details»
Metactive Medical Announces Name Change to Artio Medical - PR โฆ
Feb 11, 2020 The organization has since grown to include a team of exceptionally talented medical device professionals and expanded its focus to include flexible polymer implants to โฆSee details»
Metactive Medical Changes Name to Artio Medical
Feb 11, 2020 Artio Medical was founded in 2014 as a small research and development group focused on developing metal implants for vascular embolization. The organization has since โฆSee details»
Metactive Medical Announces Name Change to Artio Medical
Feb 12, 2020 The organization has since grown to include a team of exceptionally talented medical device professionals and expanded its focus to include flexible polymer implants to โฆSee details»
Artio Medical - Overview, News & Similar companies
Jan 3, 2022 View Artio Medical (www.artiomedical.com) location in Kansas, United States , revenue, industry and description. Find related and similar companies as well as employees โฆSee details»
Artio Medical Inc - Company Profile and News - Bloomberg Markets
Company profile page for Artio Medical Inc including stock price, company news, executives, board members, and contact informationSee details»
Artio Medical - PitchBook
Developer of medical devices designed to create innovative products for the treatment of peripheral vascular, neurovascular, and structural heart diseases. The company's products are โฆSee details»
Artio Medical, Inc. - Manufacturer Of Medical Devices
At Artio, we are committed to developing and commercializing novel, best-in-class medical devices that have the potential to provide better patient outcomes. Delivering innovative โฆSee details»
Artio Medical - Craft
Artio Medical (formerly known as Metactive Medical) is a company that develops endovascular medical devices designed to treat peripheral and neurovascular diseases. Its devices offer โฆSee details»
Artio Medical Expands Leadership Team, Hires General Counsel โฆ
Dec 8, 2020 About Artio Medical Artio Medical is a medical device company committed to developing innovative products for the treatment of peripheral vascular, neurovascular, and โฆSee details»
Artio Medical Announces Successful First Human Use of the โฆ
Jan 27, 2021 Artio Medical is a medical device company committed to developing innovative products for the treatment of peripheral vascular, neurovascular, and structural heart diseases. โฆSee details»
Artio Medical Closes $28M in Additional Series A Financing - PR โฆ
Jun 16, 2022 /PRNewswire/ -- Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology...See details»
Artio Medical Appoints Abhinav Shukla to Board of Directors
Jun 24, 2021 Artio Medical is a medical device company committed to developing innovative products for the treatment of peripheral vascular, neurovascular, and structural heart diseases. โฆSee details»
Artio Medical Announces New Finance and Operations Leadership โฆ
Sep 16, 2021 /PRNewswire/ -- Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart...See details»
Artio Medical Welcomes Clinical, Regulatory, and Quality Executives
Jul 14, 2021 /PRNewswire/ -- Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart...See details»
Artio Medical Appoints New Head of Human Resources
Jan 26, 2022 Giorgini has a passion for creating one-of-a-kind programs to create, motivate, and lead cross-functional teams within an organization. She joined Artio from Bardavon Health โฆSee details»
Artio Medical closes US$28 million in additional Series A financing
Jun 16, 2022 Artio Medical today announced the closing of US$28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised by the company to date to โฆSee details»
Artio Medical Closes Tranche of $12 Million in Series A Financing
Apr 29, 2021 For more information, please visit www.artiomedical.com. About the AmplifiโขVein Dilation System An estimated 2.3 million end-stage renal disease patients require life โฆSee details»
Artio Medical (@ArtioMedical) | Twitter
Dec 31, 2021 The latest Tweets from Artio Medical (@ArtioMedical). At Artio, we are committed to developing and commercializing novel, best-in-class medical devices that have the potential โฆSee details»